RUNX2 and cleidocranial dysplasia 1: To define the relevance of polyA CCs to the in vivo aggregation and toxicity of proteins involved in human polyA-expansion diseases, we focused on the transcription factor RUNX2 (Fig. 3; Supplementary Material, Fig. S3A), the molecular mediator of cleidocranial dysplasia upon polyA expansion.